Roka Bioscience Q4 Revenues Rise 7 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Roka Biosciences reported after the close of the market Friday that its fourth quarter revenues rose 7 percent from the fourth quarter of 2014.

For the three-month period ended Dec. 31, the molecular diagnostics firm reported revenues of $1.5 million compared to $1.4 million in the same period the year before.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.